Search results
Added:
1 year ago
Complete LAA exclusion (LAAE) should always be part of any discussion about management of AF patients undergoing cardiac surgery.
And here’s why…
Thrombus in the LAA is believed to be the primary cause of stroke in AF patients1-3
LAAE has been shown to reduce stroke and bleeding risk1,4-6,9
Expert consensus supports the use of LAAE during concomitant cardiac surgery1,7,8
…
View more
Harry Crijns
Research Area(s) / Expertise:
Author
Presented at EHRA 2021
Author(s):
A John Camm
,
Hugh Calkins
,
Claudio Tondo
Start date:
Apr 24, 2021
Broadcast
Keitaro Senoo
Research Area(s) / Expertise:
Job title: Kyoto Prefectural University of Medicine, Kyoto, JP
Author
Added:
11 months ago
EHRA 2023 — Investigator, Prof Nicolas Doll (Schuechtermann-Klinik, DE) joins us to discuss the take-home messages from the international prospective randomised multi-centre CEASE-AF study (NCT02695277).
In a randomized controlled trial, 146 patients were enrolled to compare the safety, efficacy, and quality of life outcomes of a combined epicardial surgical plus endocardial catheter technique…
View more
Author(s):
Jonathan Piccini
Added:
1 year ago
AHA 22 - Dr Jonathan Piccini(Duke University Medical Center, Durham, US) joins us to discuss the findings of the NOVA Phase II trial (NCT03779841).
NOVA Phase II is a multicenter, randomized, dose-ranging study that aims to find the efficacy and safety of botulinum toxin type A (AGN-151607) (AbbVie)in preventing post-operative atrial fibrillation (POAF) in patients undergoing open-chest cardiac…
View more
John M Miller
Research Area(s) / Expertise:
Author
Author(s):
Carina Blomström-Lundqvist
,
Jason G Andrade
,
Yassir Javaid
,
et al
Start date:
Feb 24, 2021
View more
Eue-Keun Choi
Research Area(s) / Expertise:
Job title: Professor
Author